Potential prognostic value of rheumatoid factor in anti-aquaporin 4-immunoglobin G-positive neuromyelitis optica spectrum disorders

IF 3.6 3区 医学 Q1 CLINICAL NEUROLOGY
{"title":"Potential prognostic value of rheumatoid factor in anti-aquaporin 4-immunoglobin G-positive neuromyelitis optica spectrum disorders","authors":"","doi":"10.1016/j.jns.2024.123215","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Neuromyelitis optica spectrum disorder (NMOSD) is the central nervous system demyelinating disease differentiated from multiple sclerosis by the presence of anti-aquaporin 4-antibody (AQP4-ab), which is sometimes accompanied by non-organ-specific autoantibodies.</p></div><div><h3>Methods</h3><p>We prospectively collected clinical information and profiles of non-organ-specific autoantibodies such as fluorescent antinuclear (FANA), anti-Sjögren's syndrome A (SSA)/Ro, anti-SS B (SSB)/La, anti-neutrophil cytoplasmatic (ANCA), lupus anticoagulant (LA), anti-cardiolipin (ACA), anti-double-stranded DNA (dsDNA), rheumatoid factor (RF), anti-thyroperoxidase, and anti-thyroglobulin antibodies in patients with NMOSD. Clinical characteristics and laboratory findings of patients with NMOSD with or without autoantibodies were analyzed. Cox proportional hazard models were used to identify independent risk factors predicting high disability in patients with NMOSD.</p></div><div><h3>Results</h3><p>A total of 158 patients with NMOSD (Female: Male = 146:12; age, 36.11 ± 14.7) were included. FANA was observed most frequently (33.3 %), followed by anti-SSA (28.6 %), anti-SSB (10.0 %), RF (8.5 %), anti-dsDNA (7.0 %), LA (4.7 %), ACA (4.8 %), and ANCA (2.4 %). High disability (Expanded Disability Status Scale (EDSS) score ≥ 6) was observed more frequently in patients with RF (45.5 %) than in those without RF (14.5 %) (<em>p</em> = 0.02). RF was a significant predictive factor for the high disability (hazard ratio [HR], 3.763; 95 % confidence interval [CI], 1.086–13.038; <em>p</em> = 0.037), age at onset (HR, 1.093; 95 % CI, 1.05–1.14; <em>p</em> ≤0.001), and annual relapse rate (ARR) (HR, 4.212; 95 % CI, 1.867–9.503; <em>p</em> = 0.001).</p></div><div><h3>Conclusion</h3><p>Organ-specific and non-organ-specific autoantibodies are frequently observed in Korean patients with AQP4-ab-positive NMOSD. RF may be an independent predictor of high disability, along with age at onset and ARR.</p></div>","PeriodicalId":17417,"journal":{"name":"Journal of the Neurological Sciences","volume":null,"pages":null},"PeriodicalIF":3.6000,"publicationDate":"2024-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the Neurological Sciences","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0022510X24003502","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Neuromyelitis optica spectrum disorder (NMOSD) is the central nervous system demyelinating disease differentiated from multiple sclerosis by the presence of anti-aquaporin 4-antibody (AQP4-ab), which is sometimes accompanied by non-organ-specific autoantibodies.

Methods

We prospectively collected clinical information and profiles of non-organ-specific autoantibodies such as fluorescent antinuclear (FANA), anti-Sjögren's syndrome A (SSA)/Ro, anti-SS B (SSB)/La, anti-neutrophil cytoplasmatic (ANCA), lupus anticoagulant (LA), anti-cardiolipin (ACA), anti-double-stranded DNA (dsDNA), rheumatoid factor (RF), anti-thyroperoxidase, and anti-thyroglobulin antibodies in patients with NMOSD. Clinical characteristics and laboratory findings of patients with NMOSD with or without autoantibodies were analyzed. Cox proportional hazard models were used to identify independent risk factors predicting high disability in patients with NMOSD.

Results

A total of 158 patients with NMOSD (Female: Male = 146:12; age, 36.11 ± 14.7) were included. FANA was observed most frequently (33.3 %), followed by anti-SSA (28.6 %), anti-SSB (10.0 %), RF (8.5 %), anti-dsDNA (7.0 %), LA (4.7 %), ACA (4.8 %), and ANCA (2.4 %). High disability (Expanded Disability Status Scale (EDSS) score ≥ 6) was observed more frequently in patients with RF (45.5 %) than in those without RF (14.5 %) (p = 0.02). RF was a significant predictive factor for the high disability (hazard ratio [HR], 3.763; 95 % confidence interval [CI], 1.086–13.038; p = 0.037), age at onset (HR, 1.093; 95 % CI, 1.05–1.14; p ≤0.001), and annual relapse rate (ARR) (HR, 4.212; 95 % CI, 1.867–9.503; p = 0.001).

Conclusion

Organ-specific and non-organ-specific autoantibodies are frequently observed in Korean patients with AQP4-ab-positive NMOSD. RF may be an independent predictor of high disability, along with age at onset and ARR.

类风湿因子在抗喹诺酮 4-免疫球蛋白 G 阳性神经脊髓炎视网膜频谱疾病中的潜在预后价值。
背景:神经脊髓炎视网膜谱系障碍(NMOSD)是一种中枢神经系统脱髓鞘疾病,它与多发性硬化症的区别在于存在抗quaporin 4-抗体(AQP4-ab),有时还伴有非器官特异性自身抗体:我们前瞻性地收集了非器官特异性自身抗体的临床信息和概况,如荧光抗核抗体(FANA)、抗Sjögren综合征A抗体(SSA)/Ro、抗SS B抗体(SSB)/La、抗中性粒细胞胞浆抗体(ANCA)、狼疮抗凝物抗体(LA)、抗心磷脂抗体(ACA)、抗双链 DNA 抗体(dsDNA)、类风湿因子抗体(RF)、抗甲状腺过氧化物酶抗体和抗甲状腺球蛋白抗体。对有或无自身抗体的 NMOSD 患者的临床特征和实验室检查结果进行了分析。采用 Cox 比例危险模型确定预测 NMOSD 患者高度残疾的独立危险因素:共纳入158名NMOSD患者(女性:男性=146:12;年龄,36.11 ± 14.7)。FANA最常见(33.3%),其次是抗SSA(28.6%)、抗SSB(10.0%)、RF(8.5%)、抗dsDNA(7.0%)、LA(4.7%)、ACA(4.8%)和ANCA(2.4%)。有 RF 的患者(45.5%)比无 RF 的患者(14.5%)更容易出现高度残疾(扩展残疾状态量表(EDSS)评分≥6)(P = 0.02)。RF 是高度残疾(危险比 [HR],3.763;95 % 置信区间 [CI],1.086-13.038;p = 0.037)、发病年龄(HR,1.093;95 % CI,1.05-1.14;p ≤0.001)和年复发率(ARR)(HR,4.212;95 % CI,1.867-9.503;p = 0.001)的重要预测因素:结论:器官特异性和非器官特异性自身抗体经常出现在AQP4ab阳性的韩国NMOSD患者中。RF与发病年龄和ARR一样,可能是高致残率的独立预测因素。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of the Neurological Sciences
Journal of the Neurological Sciences 医学-临床神经学
CiteScore
7.60
自引率
2.30%
发文量
313
审稿时长
22 days
期刊介绍: The Journal of the Neurological Sciences provides a medium for the prompt publication of original articles in neurology and neuroscience from around the world. JNS places special emphasis on articles that: 1) provide guidance to clinicians around the world (Best Practices, Global Neurology); 2) report cutting-edge science related to neurology (Basic and Translational Sciences); 3) educate readers about relevant and practical clinical outcomes in neurology (Outcomes Research); and 4) summarize or editorialize the current state of the literature (Reviews, Commentaries, and Editorials). JNS accepts most types of manuscripts for consideration including original research papers, short communications, reviews, book reviews, letters to the Editor, opinions and editorials. Topics considered will be from neurology-related fields that are of interest to practicing physicians around the world. Examples include neuromuscular diseases, demyelination, atrophies, dementia, neoplasms, infections, epilepsies, disturbances of consciousness, stroke and cerebral circulation, growth and development, plasticity and intermediary metabolism.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信